Print Page  Close Window


SEC Filings

8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 05/03/2019
Entire Document
 


Case 18-10518-KG     Doc 1081     Filed 04/29/19     Page 11 of 11

 

In re: Orexigen Therapeutics, Inc.

   Case No. 18-10518 (KG)

Debtor

   Reporting Period: March 1, 2019 - March 31, 2019

 

MOR-5

Accounts Receivable Aging

As of March 31, 2019

(Unaudited)

 

$ USD ‘000s

                 
        
Accounts Receivable Aging    Current      0-30 Days      31-60 Days      61-90 Days      91 Days +      Total  

Accounts Receivable, net

     $                     -      $                     -      $                     -      $                     -      $                     -      $                     -  
  

 

 

 
     $                     -      $                     -      $                     -      $                     -      $                     -      $                     -  

Debtor Questionnaire

 

Must be completed each month          Yes                No      
1.   Have any assets been sold or transferred outside the normal course of business
this reporting period? If yes, provide an explanation below.
        X
2.   Have any funds been disbursed from any account other than a debtor in possession
account this reporting period? If yes, provide an explanation below.
        X
3.   Have all post petition tax returns been timely filed? If no, provide an explanation
below.
   X     
4.  

Are workers compensation, general liability and other necessary insurance

coverages in effect? If no, provide an explanation below.

   X     
5.   Has any bank account been opened during the reporting period? If yes, provide
documentation identifying the opened account(s). If an investment account has been
opened provide the required documentation pursuant to the Delaware Local Rule 4001-3.
        X